Health
Regulating fas protein may be a route to prevent cancer relapse after immunotherapy – News-Medical.Net
Mount Sinai researchers have solved one of the enduring mysteries of cancer immunotherapy: Why does it completely eliminate tumors in many patients, even when not…
Mount Sinai researchers have solved one of the enduring mysteries of cancer immunotherapy: Why does it completely eliminate tumors in many patients, even when not all the cells in those tumors have the molecular target that the therapy is aimed at?
The answer involves a protein called fas, and regulating fas may be a route to preventing cancer relapse, the researchers reported in a study published in Cancer Discovery in December.
Cancer immunotherapies target antigens, or proteins, on the surface…
-
General19 hours agoAbattoir worker in serious condition after workplace accident in Echuca
-
General20 hours agoWoman who reported NSW MP Gareth Ward’s alleged sex crimes cross-examined
-
Noosa News10 hours agoFull house as Minister shares vision for Sunshine Coast transport
-
General22 hours agoIsraelis are being forced underground in major cities as Iranian missiles rain down in retaliatory strikes